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ABSTRACT 
A cross sectional study was conducted among diabetic patients in Kelantan, Malaysia to 
determine the prevalence of erectile dysfunction (ED}, characteristics of diabetic 
patients with ED and patient's knowledge, attitude and practice towards ED. A total of 
156 patients from Diabetic Clinic, Klinik Kesihatan Bandar, Kota Bharu and Hospital 
Universiti Sains Malaysia (USM), Kubang Kerian were selected into the study by using 
the availability sampling technique. Respondent were given self-administered 
questionnaire. ED was determined by using the International Index Of Erectile Function 
(IIEF-5). Statistical Program for Social Science (SPSS) version 9.0 was used for 
analyzing the data. The mean age was 53.2 ± 9.18 year. Majority of patients were Type 
2 diabetes (97.6%). The overall prevalence of ED was 77.8% in which the prevalence of 
severe ED was 36.7%. There was significant correlation between age, duration of 
diabetes, history of smoking and retinopathy with ED (p<0.05). There was no 
significant correlation between presence of concomitant diseases with ED (p>0.05). 
Majority of patients (86%) had poor knowledge regarding ED. On comfort discussing 
about ED with the health provider, 18.2 % felt very comfortable, 32.5% felt 
comfortable, 15.9% felt quiet comfortable, 15.1% felt between comfortable and 
uncomfortable, 15.9% felt uncomfortable and 2.4% felt very uncomfortable. Regarding 
seeking treatment, 57.1% would do so. This study showed a high prevalence of ED in 
diabetic patients. The main factors associated with ED were age, duration of diabetes, 
history of smoking and retinopathy. Patients also considered the information on nature 
of ED and possible treatment were scant and generally inadequate. 
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ABSTRAK 
Satu kajian irisan lintang telah dijalankan di kalangan pesakit kencing manis (DM) di 
Kelantan, Malaysia untuk mengenalpasti prevalens penyakit kegagalan ereksi (ED), ciri-
ciri pesakit yang menghidap ED dan menilai pengetahuan, sikap dan tingkahlaku 
pesakit terhadap ED. Sejumlah 156 pesakit di Klinik Kencing Manis, K.linik Kesihatan 
Bandar, Kota Bharu dan Hospital USM dipilih menyertai kajian secara teknik 
persampelan availabiliti. Pesakit diberikan borang soal-selidik untuk dijawab sendiri. 
Kegagalan ereksi ditentukan dengan menggunakan lndeks Kegagalan Ereksi 
Antarabangsa (IIEF-5). Data yang diperolehi dianalisa dengan menggunakan pogram 
statistik iaitu "Statistical Program for Social Science (SPSS) version 9.0". Purata umur 
adalah 53.2 ± 9.18 tahun. Majoriti pesakit adalah diabetes 'type 2' {97.6%). Prevalens 
ED adalah 77.8% di mana prevalens ED peringkat teruk adalah 36.7%. Terdapat 
korelasi yang signifikan di antara umur, jangkamasa penyakit, sejarah merokok, 
retinopati dan ED (p<O.OS). Kewujudan penyakit lain tidak mempunyai pengaruh yang 
signifikan ke atas ED (p>O.OS). Majoriti pesakit (86%) mempunyai pengetahuan yang 
lemah ten tang ED. Dalam membincangkan penyakit ED dengan petugas kesihatan, 
32.5% merasa selesa dan 18.3% merasa amat selesa 15.9% merasa agak selesa, 15.1% 
merasa antara selesa dan tidak selesa, 15.9% merasa tidak selesa dan 2.4o/o merasa 
sangat tidak selesa. Dalam mendapatkan rawatan, 57.1% akan berbuat demikian. Kajian 
ini menunjukkan prevalens ED yang tinggi di kalangan pesakit kencing manis. Faktor-
faktor yang mempengaruhi ED adalah umur, jangkamasa penyakit DM dan retinopati. 
Penerangan mengenai ED secara umumnya adalah sedikit dan tidak mencukupi. 
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1.0 INTRODUCTION 
1.1 Overview 
Erectile dysfunction (ED) is defined as "the inability to attain and/or to 
maint~in penile erection sufficient for satisfactory sexual performance" 
(Impotence: NIH Consensus Conference, 1993). It affects millions of men 
throughout the world {Impotence: NIH Consensus Conference, 199 3). Although 
for some men erectile function may not be the best or most important measure of 
sexual satisfaction, for many men ED creates mental stress that affects their 
interactions with family and associates. ED is a symptom not a disease, however 
it can herald a serious medical problem. 
Until recently, ED was one of the most neglected complications of 
diabetes (Neelima V Chu et al, 2001). In the past, physicians and patients were 
led to believe that declining sexual function was an inevitable consequence of 
advancing age or was brought on by emotional problems. This misconception, 
combined with men's natural reluctance to discuss their sexual problems and 
physicians' inexperience and unease with sexual issues, resulted in failure to 
directly address this problem with the majority of patients experiencing it 
(Neelima V Chu e.( a/, 2001). 
9 
1.2 Epidemiology 
Several studies regarding the epidemiology, risk factors and treatment of 
ED had been done among men (Fieldman HA et al, 1994, Kongkanan A, 2000, 
Tambi I, 1998). In the Massachusetts Male Aging Study which involved 1290 
men aged 40-70 years, the prevalence of ED was 52%; 17.1% mild ED, 25.2% 
moderate ED and 9.6% complete ED (Fieldman HA et al, 1994). In the Thai 
Erectile Dysfunction Study (TEDES), the prevalence of ED was 37.5%, mild 
19.1%, moderate 13.7% and severe 4.7% (Kongkanan A et al, 2000). In a study 
done in Spain in 2001 among 2476 men age 25-70 year old, the prevalence of 
ED was 18.9%. The prevalence of ED in other country presented in Table 1. 
In a large epidemiological study in Malaysia, the prevalence of minimal 
to complete ED was 60% (Tambi /, 1998). It also showed that the prevalence 
was related to age group; for moderate and complete ED, the total prevalence 
was 16%, whereas the prevalence of 65 to 70 year-old was 48%. In this study, 
diabetes mellitus was found to be the most important risk factor of ED ( Tambi 
L1998 ). 
ED is a common complication of diabetes and an important cause of 
decreased quality of life in diabetic men. The prevalence of ED among diabetic 
patients in Italy was 36% ( Fedele et al, 1998 ). The degree of ED was 
determined by asking participants to categorize themselves whether they 
complete or incomplete ED. A total of 9,868 diabetic patients were interviewed 
10 
and 3,534 ( 35.8 % ) reported ED in which 70.3% incomplete and 29.4% 
complete ED (Fedele et al, 1998). 
In African countries, the prevalence of ED among diabetic patients ranges 
· between 16% in Senegal ( Gueye SM et al, 1998) and 48.7% in Ethiopia ( Seyoum B, 
1998 ). 
Table 1: Prevalence of ED in other country 
Country Sample 
Age Prevalence of ED(%) Reference 
size range 
<1% (25-30 years) 
<3% (30-45 years) 
*USA 4108 ~25 6.7% (45-55 years) Kinsey et al, 1948 
25% (65 years) 
55% (75 years) 
*Nigeria 227 - 34% Mobede et al, 1990 
<2.5% (20-44 years) 
10% (45-59 years) 
*Japan 3490 20-90 23% ( 60-64 years) Sa to et al, 1995 
30.4% (65-69 years) 
>44.3% (~ 70 years) 
32.8% (40-49 years) 
*China 1582 ~40 
36.4% (50-59 years) Wang et al, 1997 
74.2% (60-69 years) 
86.3% ~ 70 years) 
Pakistan 585 25-70 70.6 Hussain S et al, 2000 
Turkey 1982 40-70 64.7 Akkus E at al, 2000 
Egypt 599 30-70 54.9 Mahmoud et al, 2000 
0 
Morocco 655 ?:25 53.6 Kadiri et al, 2000 
Nigeria 917 35-70 50.7 Dogunro et al,2000 
Finland 2128 50-70 48 Koskimaki et al, 2000 
Italy 2010 ~18 12.8 La Pera et al, 2000 
11 
*{Tan HM, 1999) 
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1.3 Physiology of erection 
Normal male sexual function requires a complex interaction of vascular, 
neurological, hormonal, and psychological systems (Neelima V Chu, 2001 ). 
The initial obligatory event is acquisition and maintenance of an erect penis, 
which is a vascular phenomenon. Normal erections require blood flow into the 
corpora cavemosae and corpus spongiosum. As the blood accelerates, the 
pressure within the intracavemosal space increases dramatically to choke off 
penile venous outflow. This combination of increased intracavemosal blood 
flow and reduced venous outflow allows a man to acquire and maintain a firm 
erection (Nee/ima V Chu, 2001 ). 
Erection is initiated by a central nervous system event that integrates 
psychogenic stimuli (perception, desire, etc.) and controls the sympathetic and 
parasympathetic innervation of the penis ( Impotence: NIH Consensus 
Conference Statement, 1993 ). Sensory stimuli from the penis are important in 
continuing this process and in initiating a reflex arc that may cause erection 
under proper circumstances and may help to maintain erection during sexual 
activity ( Impotence: NIH Consensus Conference Statement, 199 3 ). 
13 
Parasympathetic input allows erection by relaxation of trabecular smooth 
muscle and dilation of the helicine arteries of the penis. This leads to expansion 
of the lacunar spaces ~nd entrapment of blood by compressing venules against 
the tunica albuginea, a process referred to as the corporal veno- occlusive 
~echanism (Impotence: NIH Consensus Conference, 1993 ). The tunica 
albuginea must have sufficient stiffness to compress the venules penetrating it so 
that venous outflow is blocked and sufficient tumescence and rigidity can occur 
(Impotence: NIH Consensus Conference, 1993 ). 
Acetylcholine released by the parasympathetic nerves is thought to act 
primarily on endothelial cells to release a second nonadrenergic-noncholin~rgic 
carrier of the signal that relaxes the trabecular sn1ooth muscle(Impoten.ce: NIH 
Consensus Conference, 1993). Nitric oxide released by the endothelial cells, and 
possibly also of neural origin, is currently thought to be the leading of several 
candidates as this nonadrenergic-noncholinergic transmitter; but this has not yet 
been conclusively demonstrated to the exclusion of other potentially important 
substances (e.g., vasoactive intestinal polypeptide). The relaxing effect of nitric 
oxide on the trabecular smooth muscle may be mediated through its stimulation 
t 
of guanylate cyclase and the production of cyclic guanosine monophosphate 
( cGMP), which would then function as a second messenger in this system ( 
Impotence: NIH Consensus Conference, 1993 ). 
14 
Constriction of the trabecular smooth muscle and helicine arteries 
induced by sympathetic innervation makes the penis flaccid, with blood pressure 
in the cavemosal sinuses of the penis near venous pressure (Impotence: NIH 
Consensus Conference, 1993 ).. Acetylcholine is thought to decrease 
sympathetic tone. This may be important in a permissive sense for adequate 
trabecular smooth muscle relaxation and consequent effective action of other 
mediators in achieving sufficient inflow of blood into the lacunar spaces. When 
the trabecular smooth muscle relaxes and helicine arteries dilate in response to 
parasympathetic stimulation and decreased sympathetic tone, increased blood 
flow fills the cavernous spaces, increasing the pressure within these spaces so 
that the penis becomes erect. As the venules are compressed against the tunica 
albuginea, penile pressure approaches arterial pressure, causing rigidity. Once 
this state is achieved, arterial inflow is reduced to a level that matches venous 
outflow (Impotence: NIH Consensus Conference, 1993 ). 
Erections require neural input to redirect blood flow into the corpora 
cavemosae. Psychogenic erections secondary to sexual images or auditory 
stimuli relay sensual input to the spinal cord at T 11 to L-2. Neural impulses 
flovv to the pelvic vascular bed, redirecting blood flow into the corpora 
cavemosae. Reflex erections secondary to tactile stimulus to the penis or genital 
area activate a reflex arc with sacral roots at 82 to 84 (Neelima V Chu, 2001) 
1) 
Nocturnal erections occur during rapid-eye-movement (REM) sleep and 
occur 3-4 times nightly. Depressed men rarely experience REM sleep and 
therefore do not have nocturnal or early-morning erections ( Neelima V Chu~ 
2001 ). 
16 
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1.4 Etiology of erectile dysfunction 
As we lmow, normal erectile function requires the coordination of 
psychological, hormonal, neurological, vascular, and cavemosal factors. 
Alteration in any one of these factors is sufficient to cause ED. Not 
uncommonly, a ·combination of factors is involved. 
Among the important risk factors for ED is chronic systemic illnesses. 
Diabetes mellitus, heart disease, and hypertension are all commonly associated 
with ED (Nlli Consensus Development Panel on Impotence,1993 ). Results 
from the Massachusetts Male Aging Study showed that the age adjusted 
prevalence of complete ED was 28% in treated diabetic patients, 39% in those 
with treated heart disease, and 15% in men taking antihypertensive treatment. 
The prevalence in the whole study population was 9.6% (Fieldman HA et al, 
1994). Complete ED has also been observed to increase with the severity of 
depression; almost 90% of severely depressed men report complete ED ( G 
Wagner et al, 1998). Peripheral vascular disease leading to insufficient arterial 
blood supply is another common cause. In addition, an association between low 
plasma concentrations of high density lipoprotein and ED has been found. Other 
diseases such as peptic ulcer, arthritis, and allergy are also associated with an 
increased prevalence ofED (G Wagner eta!, 1998). 
Only a small percentage of cases of ED are due to hormonal problems. 
The role of testosterone in ED is not clear (G Wagner eta!, 1998). Some men 
continue to achieve erection even after castration. The fall in free serum 
17 
testosterone and increases in concentrations of sex hormone binding globulin 
with aging may be associated with loss of libido and reduced frequency of 
erection, but restoration of normal testosterone concentrations does not usually 
improve sexual function. Patients with hyperprolactinaemia, frequently 
associated with low testosterone values, can develop low libido and ED by 
unlmown mechanisms. Testosterone replacement treatment, without correction 
of concurrent hyperprolactinaemia, does not resolve ED associated with 
hyperprolactinaemia ( G Wagner et al, 1998). 
Poor blood supply as a result of congenital malfo~ations or trauma is a 
less common cause of ED that can affect the young male ( G Wagner et al, 1998). 
Peyronie's disease is a specific condition of the penis in which the development 
of fibrous plaques in the tunica albuginea, sometimes extending into the erectile 
tissue, may cause pain (in the early inflammatory stage) and penile deviation, 
making coitus impossible. Inability to retain pressurised blood in the corpus 
cavemosum follows disruption of the vena-occlusive mechanism, which can be 
caused by Peyronie's disease, congenital, or the result of trauma or surgery ( G 
Wagner et al, 1998 ) . The summary of multiple diseases that can contribute to 
ED are presented in Table 2 below. 
1 () J.u 
Table 2: Diseases and trauma that may contribute to erectile dysfunction 
Group Diseases I Trauma 
Central Nervous System Cerebrovascular attack Brain injury 
Parkinsonism Brain tumour 
Shy-Drager syndrome Spinal cord injury 
Myelopathy Disc herniation 
Peripheral nerve Diabetes mellitus Pelvic fracture 
Uremia Pelvic surgery 
Syphilis Transperineal surgery 
Radiotherapy 
Vascular Leriche syndrome Atherosclerosis 
Diabetes mellitus Pelvic fracture 
Endocrine Pituitary gland disorder HYJ3ogonadism 
Thyroid gland disorder Hepatic cirrhosis 
Adrenal gland disorder 
f 
Penile Hypospadia Peyronie's disease 
Fibrosis of the corpus Priapism 
cavemosum secondary Explantation of penile 
to penile rupture to prostheses 
Psychiatry Depression Performance anxiety 
Schizophrenia 
(Tan HM 1999) 
Many prescription drugs, as well as some over-the-counter medications, 
can cause ED. Around 25% of erectile failure seen in clinic patients is caused by 
medication. pressure (G Wagner et al, 1998). ED may affect 10-20% of patients 
taking thiazide diuretics, and to a lesser extent, patients who are using beta-
blocking drugs ( G Wagner et al, 1998). Evidence from Treatment Of Mild 
Hypertension Study (TOMHS) among 902 hypertensive patients, aged 45-69 
19 
years that were treated with placebo or one of five drugs: acebutolol, 
amlodipine, chlorthalidone, doxazosin or enalapril showed that he incidence of 
ED was lowest in the patients taking doxazosin and highest in those on 
chlorthalidone (a thiazide-like diuretic) (Grimm RH et a/,1997). In a treated 
hypertension patien~, ED may be a result of reduced perfusion pressure, as 
blood pressure falls in response to the medication, or probably a direct (but 
unknown) effect on smooth muscle (G Wagner et al, 1998 ). Further support for 
this mechanism comes from the obs~rvation that treatment of hypertension with 
the alpha adrenergic receptor blockers are not associated with erectile failure, 
and possibly even enhances pre-existing poor sexual function, despite lowering 
arterial blood pressure (G Wagner et al, 1998 ). 
ED commonly complicates antidepressant treatment with both 
monoamine oxidase inhibitors and tricyclic antidepressants ( G Wagner et al, 
1998). Study by. Benzodiazepines and selective serotonin reuptake inhibitors 
have been reported to cause erectile failure, decreased libido, or ejaculatory 
problems. Angel et al in 2001 comparing various antidepressant found a high 
incidence of sexual dysfunction with SSRis and venlafaxine, ranging from 58% 
to 73% (Angel et al, 2001) Cimetidine, digoxin, and metoclopramide cause ED, 
as do anabolic steroids, either through a direct effect on penile tissues or through 
suppression of normal androgen production ( G Wagner et al, 1998 ). Table 3 
below summarize the medications that can cause ED. 
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Table 3: Drugs that may cause ED 
Group Drugs 
Antihypertensives Bethanidine Clonidine 
Guanethedine Guanfacine 
• 
lndoramin Labetolol 
Methyldopa Oxprenolol 
Prazosin Reserpine 
Timolol Todralazine 
Verapamil 
Antimicrobials Ethionamide Vidarabine 
Cardiac-active agents Digoxin Disopyramide 
Diuretics Spironolactone Thiazide 
Gastrointestinal agents Cimetidine Ranitidine 
Hormones Chlormadinone acetate Ethinylestradiol 
Ethylnandrol Estramustinea 
GnRH agonists Mestanolone 
17alpha 
Methylandrostanolone Nandrolone 
Stanozolol 
Lipid-modifying drugs Clofibrate Simfibrate 
Psychotherapeutic 
drugs Amoxapine Clomipramine 
Ethyl loflazepate Haloperidol 
Maprotiline Methamphetamine 
Methylphenidate Prazepam 
Sulpiride 
(Tan HM,J999) 
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Psychogenic influences are the most likely causes of intermittent erectile 
failure in young men. Anxiety about "performance" may result in inhibitory 
sympathetic nervous system activity, and anticipatory anxiety can make the 
condition self perpetuating. A psychogenic component is often present in older 
men, secondary to an organic cause. Underlying relationship problems are a 
common cause of erectile failure and this possibility should be explored in men 
of all ages ( G Wagner et al, 1998). 
1.5 Pathology of diabetic erectile dysfunction 
The natural history of ED in people with diabetes is normally gradual 
and does not occur overnight. Pathophysiologic alterations that diabetes mellitus 
can impose on erectile physiology, is essentially a hemodynamic event with 
neural modulation. Diabetes can interfere with numerous critical erectile 
mechanisms, such as impairing arterial perfusion, producing a peripheral and 
autonomic sensory neuropathy, and altering normal corporeal smooth muscle 
activity in the penis (Lipshultz et al, 1999). Atherosclerosis in the penile and 
pudendal arteries limits the blood flow into the corpus cavernosum. Because of 
the loss of compliance in the cavernous trabeculae, the venous flow is also lost. 
This loss of flow results in the inability of the corpora cavernosae to expand and 
compress the outflow vessels (Neelima V Chu, 2001 ). 
Autonomic neuropathy is a major contributor to the high incidence of ED 
in people with diabetes ( Neelima V Chu, 2001 ).. Norepinephrine and 
acetylcholine-positive fibers in the corpus cavemosum have also been shown to 
22 
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be reduced in people with diabetes. This results in loss of the autonomic nerve-
mediated muscle relaxation that is essential for erections 
Diabetes mellitus has been found to be the strongest predictor of ED as 
well as treatment of diabetes ( Thambi I, 1998 ). It causes a decrease in quality 
of life of diabetic patients. The prevalence varies widely among studies, ranging 
from 20% to more than 70% (Fedele et al, 1998 ). Awareness of ED as a 
significant and common complication of diabetes has increased in recent years, 
mainly because of increasing knowledge of male sexual function and the rapidly 
expanding annamentarium of novel treatments being developed for ED. 
Up to now, there is no published local study concerning prevalence of 
ED amongst diabetic patients. In view of the diabetes being an important risk 
factor for ED, we need a local data concerning ED in Malaysian diabetic 
patients. 
23 
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2.0 OBJECTIVES 
2.1 To determine the prevalence of ED among known diabetic patients attending 
Diabetic Clinic, Hospital Universiti Sains Malaysia and Diabetic Clinic, 
Klinik Kesihatan Bandar, Kota Bharu, Kelantan. 
2.2 To determine the characteristics of diabetic patients with ED. 
2.3 To assess the patient's knowledge, attitude and practice towards ED. 
3.0 RESEARCH METHODOLOGY 
3.1 Research Design 
The study is a cross-sectional study . 
3.2 Site of study 
The study was carried out at Diabetic Clinic, Outpatient department, 
Klinik Kesihatan Bandar, Kota Bharu, Kelantan, Malaysia and Diabetic Clinic, 
Hospital Universiti Sains Malaysia, Kubang Kerian, Kelantan, Malaysia. 
3.3 Duration of study 
24 
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The study was carried out within 1 year from 1st January, 2000 till 31st 
December, 2000. 
3.4 Sample size 
Sample size was estimated using Epi-info version 6 (Dean AG eta/). 
With a power of 80%, a prevalence of 36% ( Fedele et a/, 1998 ) and a 
confidence interval of 95% a sample size required for the study is 98. Our study 
involved 156 diabetic patients, more than required as we continued taking 
samples till the whole one year duration. 
3.5 Respondents 
All diabetic patients attending Diabetic Clinic, Hospital Universiti Sains 
Malaysia, Kubang Kerian, Kelantan and Diabetic Clinic, Klinik Kesihatan Bandar, 
Kota Bharu, Kelantan from 1st January 2000 till 31st December 2000 were included 
in the study. 
3.6 Inclusion criteria 
Male and married diabetic patients aged 18 years and above and willing to 
participate in the study. 
3. 7 Exclusion criteria 
25 
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The exclusion criteria are single, unable to read or write and patients who 
refuse to participate. 
3.8 Approval 
The study was approved by the Research and Ethics Committee of School of 
Medical Sciences, USM, Kubang Kerian, Kelantan and National Research and 
Ethical Committee, Institute of Medical Research, Kuala Lumpur, Malaysia. 
3.9 Questionnaire 
The tool used in this study was a self-administered questionnaire. The 
questionnaire was adopted with permission from a validated questionnaire in 
Cross National Epidemiology Study of ED in Malaysia, 1998 (Thambi /, 1998) 
The questions consists of five main components i.e. demographic data, 
health practices, personal history, attitude and Sexual Health Inventory For Men 
_ International Index of Erectile Function (SHIM-liEF), knowledge about ED 
and characteristics of diabetics (appendix ) 
Patient's knowledge was classified as poor or good. Knowledge score 
was derived from a multiple choice answer type, where the respondents have to 
choose between the right or the wrong statement (close-ended or structured). 
Score I was given to the right answer, zero for incorrect and 'not sure'. All score 
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will be added to give a total score. A score 8 and below considered as poor and 
score 9 and above considered as good. 
The characteristics of diabetic patients are based on the record in the 
patient's medical notes. This include the type of diabetes, duration, treatment 
and complications, concomitant diseases and their treatments. 
A patient was considered to have history of smoking if he had smoked 
more than 1 cigarette per day for at least 1 year at any time of his life. He is 
considered to have no history of smoking if he had never smoked more than 1 
cigarette per day or had smoked more than 1 cigarette per day for less than 1 
year at any time of his life. 
The questionnaire was pre-tested among diabetic patients who attended 
medical outpatient clinic in the Medical Department, Hospital Kota Bharu to 
asses the comprehensibility. Necessary changes were made after the pretest. 
The self-administered questionnaire was distributed personally by the 
researcher to diabetic patients attending the diabetic clinics. Researcher ensured 
that the respondents has answered all the questions before collecting the 
questionnaire by reviewing the answers. 
3.10 Data analysis 
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The information collected was entered onto a personal computer using 
database software Statistical Software for Social Science (Norusis MJ). This 
software was also used for statistical analysis. Independent T -test was used to 
analyze the association between two independent continuous variables or 
between independent continuous and categorical variables. Chi-square test was 
used to analyze the association between two categorical variables. 
3.11 The International Index Of Erectile Function 
This a brief, reliable, self-administered measure of erectile function that 
is cross-culturally valid and psychometrically sound ( Raymond R. C. et al, 1997 
). It is a 15 items questionnaire scale developed by Raymond C. Rosen et al in 
1997 for assessment of erectile function. This instrument was developed in 
several stages including initial pre-testing with selected patient groups and 
expert panel consultants, followed by an intensive linguistic validation. There 
are five factors or response domain in this instrument: (1) erectile function (2) 
orgasmic function (3) sexual desire (4) intercourse satisfaction, and (5) overall 
satisfaction. ( appendix ). 
From the 15 questions, questions 2,3,4,5 and 15 is considered as Sexual 
Health Inventory For Men (SHIM) or also known as IIEF-5. This scale can be 
used to screen an ED. Each question has a scale from 0-5 except for question 15, 
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which ranges from 1-5. Possible scores range from 1-25. Patients who had score 
range from 12 to 21 is considered to be mild, 8 to 11 is moderate and less than 8 
is severe. 
4.0 RESULTS 
4.1 Descriptive statistics of the cases 
A total of 156 diabetic patients were identified during the study and 126 
patients (80.8%) participated. Fourty five patients were from Diabetic Clinic, 
Klinik Kesihatan Bandar and 111 patients were from Diabetic Clinic, Hospital 
USM. For simplicity of the study, all the patients was considered as one sample. 
Reasons for refusal were either blurring of vision or unable to read the 
questionnaire (23), involved in other study (3) and not interested to participate in 
the study (4). 
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Almost all patients (97.6%) were Type 2 diabetes (Table 4) with a mean 
age of 53.2 ±9.18 years (Table 4 and 5) with a range of 30 years to 75 years. 
The highest number of patients were in the age group 50 - 59 years. 
Mean duration of diabetes was 8.3 ± 6.95 years (Table 4 and 6) with a 
majority of less than 5 years (40.5%). 
Majority (46.8%) of the patients had secondary level of education, with 
a primary and university or college level of 26.2% and 27.0% respectively 
(Table 4). 
Mean for total monthly income was 1009.98 ± 986.97 (n=109) (Table 4 
) Ministry of Rural Development of Malaysia has defined total family income 
of less than RM 500.00 as poverty in the family of 5 peoples. Majority of 
patients (72.2%) had income more than RM 500.00, 14.3% were in the poverty 
group and 13.5% were not sure of their total household income (Table 4 ). 
Table 4. Patients details ( Mean ±_SD ) 
Number 
Age 
Type of diabetes 
Duration of dibetes 
Treatment 
30 
126 
53.2 ± 9.18 (range 30-75 ) 
Type I 
Type2 
2.4% 
97.6% 
8.3 ± 6.95 year 
Diet 5.5% 
Tablets 92.1% 
Insulin 2.4% 
History of smoking Smoking 58.7% 
Not smoking 41.3% 
• Educational level Primary 26.2% 
Secondary 46.8% 
University or college 27.0% 
Socioeconomic status RM 1009.98 ± 986.7 
( Monthly income ) RM 500.00 and above 72.2o/o 
Less than RM 500.00 14.3% 
Not sure 13.5% 
Table 5. Age distribution of patient ( n= 126) 
Frequency Total number 
Severity 
Age Group of ED (years) n (o/o) n(0/6) Mild Moderate Severe 
n(o/o) n (o/o) n(o/o) 
20-29 0 (0) 0(0) 0() 0(0) 0(0) 
30-39 8 (6.3) . 6(75.0) 6(100) 0(0) 0(0) 
40-49 37 (29.4) 27(73.0) 14(51.9) 4(8.0) 9(33.3) 
50-59 48 (38.1) 33(68.8) 14(42.4) 9(27.3) 10(30.3) 
60-69 29 (23.0) . 28(96.6) 6(21.4) 7(25.0) 15(63.6) 
70 and above 4 (3.2) 4(100) 1(25.0) 1(25.0) 2(50.0) 
Table 6. Duration of diabetes (n = 126) 
Duration of Frequency Total number Severity 
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diabetes (years) n(%) of ED Mild Moderate Severe 
n(o/o) n(%) n(%) n(%) 
1 - 5 51(40.5) 32(62.7) 18(56.2) 6(18.8) 8(25.0) 
6- 10 38(30.2) 29(76.3) 11(37.9) 7(24.2) 11(37.9) 
11- 15 24(19.0) 24(100) 7(29.2) 6(25.0) 11(45.8) 
16-20 6(4.8) 6(100) 2(33.3) 0(0) 4(66.7) 
21-25 3(2.4) 3(100) 1(33.3) 1(33.3) 1 (33.3) 
26-30 1(0.8) 1(100) 0(0) 0(0) 1(100.0) 
31-35 3(2.4) 3(100) 2(66.7) 1(33.3) 0(0) 
4.2 Concomitant disease 
Nearly half of patients has concomitant hypertension ( 46.8% ) ( Table 7 
). Less common concomitant diseases are heart disease and peptic ulcer.(Table 
7). 
Table 7. Presence of concomitant disease (n=126) 
Concomitant Disease Percent(%) 
Hypertension 46.8 
Heart disease 11.9 
Peptic Ulcer 3.2 
.. 
Depression 1.6 
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Prostatic carcinoma 0.8 
Benign Prostatic hyperplasia 0 
Prostatitis 0 
4.3 Concomitant treatments 
Patients were asked whether they take other treatments than treatment for 
diabetes, i.e. 
1. Hormonal medication, for example, androgen, anti-androgen, anti- prolactin, 
oestrogen or bromocryptine. 
2. Medication for heart disease or arrhythmia including pill and patch. 
3. Medication for gastric or duodenal ulcer. 
4. Medication for hypertension. 
5. Nervous medication, for example, sedative, anti-anxiety or anti-depression. 
6. Operation for prostatic problem. 
Majority of the patients received anti-hypertensive medications ( 39.7%) (Table 
8) as correspond to 46.8% of patients that have concomitant hypertension (Table 7). 
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This discrepancy was due to some patients have mild hypertension and they were 
advised on diet control instead of being given anti-hypertensive medication. 
-
Table 8. Treatments that patients received other 
than diabetic medication ( n = 126 ) 
Treatments Percent(%) 
Hypertension 39.7 
Heart disease 8.7 
Gastric or duodenal ulcer 4.0 
Nervous medication 1.6 
Operation for prostate 1.6 
problem 
Hormone 0.8 
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4.4 Erectile Dysfunction 
4.4.1 Epidemiology of ED 
Of the 126 patients, 78% had ED (Figure I). Majority of them fall into 
mild ED ( 42% ), 21% moderate and 3 7% severe ED (Figure 2 ). All patients in 
the age group 70 years and above had ED ( 100% compared to 96% in the age 
group 65-69 years (Table 5). All patients who had diabetes more than 10 years 
had ED ( Table 6) 
Figure 1. Distribution of patients according to 
presence of ED( n = 126) 
ED 
78% 
No ED 
22% 
Figure 2. Distribution of patients according to different 
category of ED (n =126) 
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42% 
4.4.2 Treatment for erectile dysfunction 
ED 
21% 
Eleven percent of the patients has undergone treatment for ED. Most of 
them receiving treatment in Hospital USM and are currently on follow-up. 
Figure 3. Distribution of patients according to receiving 
treatment for ED (n= l26) 
No 
89% 
36 
Yes 
11 % 
" 
4.4.3 ED awareness knowledge score regarding ED and it's treatment 
There was high percentage (75%) of patients aware of ED (Figure 5 ). 
However, the score of knowledge were poor (86%) (Figure 4 ). 
Figure 4. Distribution of patients according to knowledge 
score regarding ED and it's treatment (n = 126) 
14% 
Figure 5. Distribution of patients according to 
awareness ofED (n = 126) 
Yes 
75% 
37 
% 
4.4.4 Source of knowledge regarding ED 
We asked patients regarding sources of knowledge that they could 
identified had given them some information about ED. Among them were radio, 
television, internet, printed materials, working place, neighbour or family 
members, attending doctors and others. We found majority of patients said that 
they obtained information about ED from printed materials and from their 
neighbours or family members ( 51.6 % both ). ( Table 9) 
Table 9. Source of knowledge regarding ED (n=126) 
Source of knowledge Percentage (%) 
Printed materials 51.6 
Neighbour or family members 29.4 
Attending doctors 15.1 
Television 14.3 
Radio 10.3 
Working place 9.5 
Others 4.8 
Internet 3.2 
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When asked further, majority of them mentioned that their knowledge was not 
enough ( 72% )(Figure 6 ). 
Figure 6. Distribution of patients according to 
Not ample 
72% 
ample ofknowledge regarding ED (n = 126) 
4.4.5 Which type of treatment that patients choose as the treatment for ED? 
When asked about type of treatment for ED, 50% agreed to choose pill 
(e.g. Viagra), 44% chose hormonal, 34% chose vacuum device, and 24% chose 
intracavemosal injection (Figure 7). 
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Figure 7. Distribution of patients according to 
choice of treatment of ED (n =126) 
g Agree [ill Disagree ~ Don't know 
4.4.6 Discussing about ED with doctor 
Nearly a quarter (23%) of patients felt uncomfortable to discuss about 
ED with doctor. However 41% were comfortable and 23% were very 
comfortable. (Figure 8). 
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Figure 8. Distribution of patients according to comfortable 
in discussing about ED with doctor (n=126) 
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4.4. 7 Voluntary in telling the doctor if they are having erectile dysfunction 
On asking patients if supposed they are having an erection dysfunction, will 
they voluntarily tell their doctor even if they were not ask about it, about half of 
patients (57%) will do so (Figure 9) 
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Figure 9. Distribution of patients according to voluntary 
in telling the doctor about ED (n=126) 
4.4.8 The choice of doctor 
41 % of patients chose their primary care doctor (family physician and general 
practitioner), 37% chose urologist, 10 % chose traditional healer and 12% were not sure 
(Figure 10 ). 
Figure 10. Distribution of patients according to health provider they will 
tell voluntarily if they are having erectile dysfunction. (n =74) 
Not sure 
12% 
Traditional 
healer 
10% 
Family 
physician 
19% 
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4.5 Univariate analysis 
The characteristics of diabetic that were examined in this study are: 
1. Basic characteristic of diabetic patients which are age, mean duration of 
diabetes and smoking. 
2. Other characteristics which are concomitant diseases, medication that patient 
receives and presence of complications of diabetes. 
3. Socioeconomic factors: level of education and economical status 
These characteristics were tested to find an association with ED. 
4.5.1 Basic characteristics of diabetic patients 
We found a significant difference between mean age for diabetic patients 
with ED ( 54.2 ± 9.5 years) and patients without ED ( 49.5 ± 7.1 years ); 
p=0.015. Patients with ED had a longer duration of diabetes ( 9.4 ± 7.4 ) as 
compared to the duration of diabetes in patients without ED. This difference was 
significant (p=0.01). In the ED, we also found a higher percentage of patients 
that had history of smoking (75.0 %) compared to those without ED, where the 
percentage of no history of smoking was 53.1 %. This difference was also 
significant (p=0.038) (Table 1 0). 
43 
Table 10. Basic characteristics of diabetic patients and association with ED 
Characteristics ED No ED P value (n=98) (n=28) 
Mean age (years) 54.2 (9.5) 49.5 (7.1) P= 0.015 * 
Mean duration of diabetes (years) 9.4 (7.4) 4.39 (2.8) P=O.Ol * 
History of smoking (%) 75.0 53.1 P=0.038 ** 
* Independent t-test 
** chi-square ( ) ± standard deviation 
P < 0.05 (significant) 
4.5.2 Presence of concomitant disease and association with ED 
• Presence of concomitant diseases were found not to be associated wih 
... 
ED in diabetic patients. There was a higher percentage of hypertensive patients 
with ED (51.0%) as compared to those without ED (32.1%). In contrast, higher 
percentage of patient with heart disease was found in patient without ED 
(17.9o/o) as compared to those with ED (10.2%). These difference however 
statistically not significant. (Table 11) 
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Table 11. Presence of concomitant disease and association with ED 
Concomitant disease ED No ED P value (n=98) (n=28) 
Hypertension (%) 50(51.0) 9(32.1) P= 0.077 * 
.. 
Heart disease (%) 10(10.2) 5 (17.9) P=0.270 * 
Gastric or duodenal ulcer (%) 2(7.1) 2(2.0) P=0.174 * 
Depression(%) 2(2.0) 0(0) P=0.446 * 
Prostatic carcinoma(%) 1(1.0) 0(0) P=0.592 * 
Benign prostatic hyperplasia(%) 0(0) 0(0) -
Prostatitis(%) 0(0) 0(0) -
• 
., 
-. 
* chi-square 
() percent% 
P < 0.05 (significant) 
4.5.3 Medication or treatment that patients received and association with ED 
We tested the association between type of treatment or medications that 
patients received between those who had ED and those without ED. Though 
there were substantial number of patients in ED group received medications for 
hypertension and high percentage received medications for their diabetes, the 
difference was not significance. Only one (1.0%) patient received hormonal 
medication. For heart disease, 9.2% in ED group received medication, whereas 
7.1% in non-ED group ( Table 12 ). None of these difference were statistically 
significant. 
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Table 12. Treatment that patients received other than for diabetes 
and association with ED 
Medication ED No ED P value (n=98) (n=28) 
Oral hypoglycemic agent or insulin (%) 94(95.9) 25(89.3) P=O.l77 * 
... 
Anti-hypertensive medication(%) 42(42.9) 8(28.6) P=O.l73 * 
Medication for heart disease or 9(9.2) 2 (7.1) P=0.736 * 
arrhythmia included pill and patch (%) 
Medication for gastric or duodenal 5(5.1) 0(0) P=0.233 * 
ulcer(%) 
Hormonal medication e.g androgen, 
anti -androgen, anti -prolactin, oestrogen 1(1.0) 0(0) P=0.592 * 
or bromocryptine (%) 
* chi -square 
() percent% 
P < 0.05 (significant) 
4.5.4 Presence of complications of diabetes and association with ED 
For the presence of complications, we found only retinopathy was 
significantly associated with ED (p=0.005). 23.5% of ED patient had 
retinopathy, meanwhile, none in the non-ED group had retinopathy (Table 13) 
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Table 13. Presence of complications of diabetes and association with ED 
Diabetic complications ED No ED P value (n=98) (n=28) 
Sensory motor neuropathy (%) 38(38.8) 8(28.6) P=0.323 * 
Retinopathy(%) 23(23.5) 0(0) P=0.005 * 
Nephropathy(%) 15(5.3) 1(3.6) P=O.lOO * 
Cardiopathy (%) 7(7.1) 2 (7.1) P=l.OOO * 
Arteriopathy (%) 3(3.1) 0(0) P=0.349 * 
Diabetic foot (%) 3(3.1) 0(0) P=0.349 * 
Autonomic neuropathy (%) 0(0) 0(0) -
* chi-square 
() percent% 
P < 0.05 (significant) 
4.5.5 Level of education and association with knowledge score 
As mentioned before, majority of patients had poor knowledge score 
(Figure 4). We further tested whether there was an association between level of 
education and knowledge score of patients. It was found majority of patients 
with good knowledge score had a university and college level of education 
(55.6%). In the poor knowledge score group, majority of patients (49.1%) had a 
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secondary level of education. There was a significant association between level 
of education and knowledge score (p=0.008). (Table 14) 
Table 14. Level of education and association with knowledge score 
., 
Knowledge score 
Level of education Good Poor 
(n=18) (n=108) 
University and college(%) 10(55.6) 23(21.3) 
Secondary (%) 6(33.3) 53(49.1) 
Primary(%) 2(11.1) 32 (29.6) 
p = 0.008 * 
' 
* chi-square 
() percent% 
P < 0.05 (significant) 
4.5.6 Socio-economic status and association with knowledge score 
., 
We also tested whether there was an association between socio-economic 
status and patient's knowledge. Majority of patients with good knowledge score 
were in the group above RM 500.00 (72.2%) (Table 15). In the poor knowledge 
score group, majority of patients were in the group of more than RM 500.00 
(72.2%) (Table 15). There was a significant association between socio-
economic status and knowledge score (p=0.046) (Table 15) 
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Table 15. Socio-economic status and association with knowledge score (n=109) 
Knowledge score 
Household monthly income Good Poor 
(n=18) (n=l08) 
RM 500.00 and above 13(72.2) 78(72.2) 
., 
Below RM 500.00 0(0) 18(16.7) 
Not sure 5(27.8) 12(11.1) 
p = 0.046 * 
* chi-square 
() percent% 
p < 0.05 (significant) 
4.5.7 Level of education and association with treatment seeking attitude 
. ., Level of education was also found to be significantly associated with 
treatment seeking attitude (p=O.O 1 0). It was found that majority of patients that 
will tell their doctor voluntarily if they had ED had a secondary level of 
education (43.1%). Those who will not tell their doctor voluntarily, majority of 
them also had a secondary level of education (51.9%) (Table 16 ). 
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Table 16. Level of education and association with treatment seeking attitude 
Tell doctor voluntarily 
Level of education Yes No 
(n=72) (n=54) 
University and college(%) 26(36.1) 7(13.0) 
, 
Secondary (%) 31(43.1) 28(51.9) 
Primary(%) 15(20.8) 19 (35.2) 
p = 0.010 * 
* chi -square 
() percent% 
P < 0.05 (significant) 
4.5.8 Socio-economic status and association treatment seeking attitude 
Socioeconomic status was found not to be significantly associated with 
treatment seeking attitude (p=0.68). Majority of patients that will tell their 
doctor voluntarily if they had ED patients were in the group of RM 500.00 and 
above (72.2o/o) and of those who will not tell their doctor voluntarily, 72.2%) 
were also in the group ofRM 500.00 above. (Table 18) 
0 
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Table 17. Socio-economic status and association with treatment seeking attitude 
TeD doctor voluntarily 
Household monthly income Yes No 
(n=72) (n=54) 
RM 500.00 and above(%) 52(72.2) 39(72.2) 
Below RM 500.00 (%) 9(12.5) 9(16.7) 
Not sure 11(15.3) 6(11.1) 
P=0.680 * 
* chi-square 
() percent% 
p < 0.05 
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5.0 DISCUSSIONS 
5.1 General 
This is the first study looking at the prevalence and characeristics of 
diabetic patients with ED in Kota Bharu, Kelantan, Malaysia. The study 
population consisted of men aged 18 and above that has been treated and follow-
up in an outpatient setting in two specialised clinic in Kota Bharu Kelantan. 
Most of the patients who attended Diabetic Clinic in Outpatient Department, 
Hospital Kota Bharu were self-referred, meanwhile most of the patients 
attended Diabetic Clinic, Hospital USM were either referred by other clinic in 
Hospital USM or by health centers. Therefore, this sample of patient cannot be 
considered as representative of male diabetic population in Kelantan 
Respondents ( 156) were more than the calculated sample size. The 
response rate was 80.8%, higher than the previous study done among 
Caucassian (53%) (Fieldman HA, 1994). But lower than study done in diabetic 
patients in Italy (97.2%) (Fedele et al,1998). 
In our study, 23 patients (19.2%) were excluded from the study because 
of various reasons, such as unable to read the questionnaire, single and refused 
to participate. Our exclusion rate was higher when compared with study by 
Fedele in Italy. Out of 10,157 men, 289 (2.8%) refused to participate. 191 
refused for "personal" reason and 98 refused on account of their clinical 
conditions (Fedele et al, 1998) 
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The mean age of patients was 53.2 ± 9.18 years lower than study in 
Spain among 102 diabetic patients ( 63 ± 12 years) (Alonso Sandoica E et a!, 
1997) but higher than the study in Ethiopia (41.4 ± 15.5 years) (Seyoum Bet a!, 
1998). For age distribution, there was a highest frequency of patients in 50-59 
years age group ( 38.1 %). There was an increase of number of patients from 
6.3% in the age group 30 -39 years, to 29.4% in the age group 40-49 years and 
to 38.1% in the age group 50-59 years. But the number decreased in age group 
60-69 years (23%) and in age group 70 and above it was 3.2%. Study done in 
Italy by Dominico Fedele, 1997, shows a different trend. The number of diabetic 
patients were increasing from 3.2% in the age group 20-29 years, to 5.9% in the 
age group 30-39, to 15.3% in the age group 40-49, to 33.5% in the age group 50-
59 and to 42.0% in the age group 60-69 years. 
In our study most of patients were type 2 diabetes (97.6%). It 
corresponds with a high prevalence (9 5%) of type 2 diabetes in Malaysian 
diabetes, reported in National Cardiovascular Risk Factor Prevalence Study, 
1995. (Malaysian Second National Health and Morbidity Survey, 1997). 
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5.2 Erectile Dysfunction 
5.2.1 Prevalence of ED 
The prevalence ED in our study was 78%. It was higher than prevalence 
among diabetic patients in Italy (35.8%) (Fedele et a/, 1997), Great Britain 
(56%) (Me Cullough et al,)., Ethiopia (48.7%) (Seyoum B et al, 1998) and 
Senegal (16%) (Gueye SM et al, 1998). 
Among non-diabetic patients, the prevalence of ED in our study was still 
higher compared to MMAS study (52%) (Fieldman HA, 1994). In the MMAS, 
Fieldman mentioned the probability of severe ED of 28% in diabetic patients. A 
nationwide study of 1 ,250 urban Thai men aged between 40 and 70 years done 
in year 2000 revealed prevalence of ED of 37.5 % (Thai ED Epidemiologic 
Study Group (TEDES), 2000) . 
The difference of these result could be explained by the different tools 
that were used to diagnosed ED. Most of these other studies using a subjective 
assessment of ED as their diagnostic tool. Fedele used a self-rated questionnaire 
as a tool to diagnose ED. Patients were asked about their ability to achieve and 
maintain an erection for satisfactory sexual performance. If the answer was 
unsatisfactory, they will be further asked to classify themselves as having mild, 
moderate or severe ED. Furthermore the study was conducted by interview, 
which will cause bias. Studies done by Me Cullough et al, Seyoum B et al and 
Gueye et al used a similar approach to diagnose ED. The exception was 
Massachusettes Male Aging Study. Henry A. Fieldman, was also using a 
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subjective assessment called 'Sexual activity questionnaire ' which consist 9 
items., but to establish the result he further did a validity test. 
In contrast to our study, we were using International Index of Erectile 
Function questionnaire to diagnose ED. The reason for using an objective 
assessment of ED was because many data has shown that majority of cases of 
ED are organic in origin (Eli Coleman, 1998). Through greater medical study of 
problem of ED, people realize that there are many biomedical problems which 
contribute to ED and no longer believe that this is primarily a psychological 
problem (Eli Coleman, 1998, NIH, 1994). Interestingly, Henry A. Fieldman gave 
a different view of opinion in explaining the use of subjective assessment to 
assess ED. He stated that, potency which was defined as 'satisfactory functional 
capacity for erection', may coexist with some degree of ED in the sense of 
submaximal rigidity or submaximal capability to sustain an erection, therefore, 
ED is best defined by the individual's assessment of his own situation in simple 
terms of minimal, moderate or severe ED. 
For men both with and without diabetes, the prevalence in Malaysia was 
lower, 60% (Thambi L 1998). In Massachussettes Male Aging Study, 1994, the 
combined prevalence of mild, moderate and severe ED was even lower, 52% 
(Henry A. Fieldman, 1994) . 
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5.2.2 Different category of ED 
By using the httemational htdex of Erectile Function, we further classify 
the patients with ED. Prevalence of severe ED was 37%, moderate ED was 21% 
and mild ED was 42% (Figure 2). 
Previous studies in diabetic patients only mentioned the relationship 
between mild, moderate and severe ED with certain characteristics of diabetes 
namely, age group and duration of diabetes. None of them mentioned 
specifically the prevalence of different category of ED (Fedele et a/, 1998, 
SeyoumB eta/, 1998, Gueye et al, 1998) 
Among non-diabetic patients, in study among 1 ,290 men age 40 -40 
years in Massachusettes Male Aging Study, 1994, the prevalence of severe ED 
(complete ED) was 9.6%, moderate ED was 25.2% and mild ED (minimal ED) 
was 17.2%. 
Study in Thailand by Thai Erectile Dysfunction Epidemiologic Study 
Group (TEDES), 2000 revealed 19.1% of males with mild dysfunction, 13.7% 
and 4.7% of males had moderate and severe dysfunction. Meanwhile Edson 
Duarte Moreira et al, in his study in Brazil found a prevalence of severe 
ED was 2.6%, moderate ED was 18.3% and mild ED was 26.6% . 
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5.2.3 Treatment of ED 
In spite of high prevalence of ED, we found a low percentage of patients 
(11 %) on treatment (Figure 3). In a study done by KM Dunn et al in United 
Kingdom in. 1998, among 281 male patients who had sexual dysfunction, only 
6% of them actually receiving treatment (KM Dunn et al, 1998). In our study, 
the treatment was a coincidence because these patients were attending Diabetic 
Clinic in Hospital USM and Hospital USM is a teaching hospital where many 
patients were expected to had been involved in certain studies conducted in the 
hospital, therefore some of our patients had been given treatment for their ED 
problem. The reason that other patients who are still not getting any treatment 
for their ED could be undiagnosed ED. The patient might not been screened for 
ED. The other reason could be, the tool that the doctor use to diagnose ED, 
where there could be a discrepancy between subjective assessment and objective 
assessment of ED. If it is so, knowledge of the doctor regarding ED plays an 
important aspect identifying patients with ED. Furthermore current 
recommendation by Malaysian Erectile Dysfunction Council And Training 
(MEDACT) is to ask every male diabetic patient about their erectile function . 
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5.3 Characteristics of diabetic patients and its association with ED 
5.3.1 Age 
Relationship between age and ED was well established (Henry A. 
Fieldman et a!, 1994). Our study found a significant difference between mean 
age for diabetic patients with ED (54.2 ± 9.5 years) and mean age of those 
without ED (49 ± 7.1), (p=0.015) (Table 10). 
In relation to age group, many previous studies had found that there was 
a significance increase in prevalence of of ED with the increase of age. Thambi 
I in 1997 found in his Cross National Epidemiology Study in Malaysia, the 
prevalence of moderate to severe ED for men between ages of 65-70 years was 
48%, increased significantly over that for men between the ages 40-45 (9%) 
(Thambi L 1997). In the Massachusettes Male Aging Study, the prevalence of 
severe erectile dycfunction tripled from 5-15% between subject ages 40 and 70 
years old (Henry A. Fieldman, 1994). 
Study by Edson Duarte Moreira et al in Brazil similarly found an 
increasing trend of not only in the frequency of ED, but also severity of ED with 
increasing age. The frequency of moderate and severe ED increased from 8.3% 
and 1.1 %, respectively, in subjects younger than 40 years old, to 27.8% and 
11.1% among men 70 years old and older. The prevalence of mild erectile 
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dysfunction remained stable at approximately 32%. (Edson Duarte Moreira et 
al, 2001). 
Similar trend was shown by study done among 1517 non-
institutionalized men aged 23-79 years in Japan. The prevalence of moderate and 
severe cases of ED were 1.8% and 0% for ages 23-29; 2.6% and 0% for ages 30-
39; 7.6% and 1.0% for ages 40-49; 14.0% and 6.0% for ages 50-59; 25.9% and 
15.9% for ages 60-69; and 27.9% and 36.4% for ages 70-79 years, respectively 
(Marumo Ketal, 2001). 
For study among diabetic patients in Italy, Fedele showed that the 
prevalence was increase with age. Prevalence in the age group 20-39 years was 
4.6%, 30-39 years was 11.6%, 40-49 years was 22.9%, 50-59 years was 36.8% 
and 60-69 years was 45.5%. Me Cullogh et al, in 541 patients also reported an 
increasing prevalence of ED with age, 11% at 20-34 years, 33% at 35-49 years 
and 51% at 50-59 years. 
Our study showed a similar trend of prevalence of ED in relation to the 
increasing of age of patient (Table 5). The prevalence of ED was 75% in age 
group 30-39 years. The prevalence for age group 40-49 was more less the same, 
73%. The prevalence increased to 96% in the age group 60-69 years an 100% in 
the age group of more than 70 years. 
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However, in term of severity of ED, the prevalence of mild, moderate 
and severe cases of ED showed a slight difference. The difference was seen in 
the distribution of mild ED (Table 5). The prevalence was 100% in age group 
30-39 years, decreased to half, 51.9% in age group 40-49 years, and further 
decresed to quarter, 25.0% in the age group 70 years and above. 
For moderate ED was 14% in the age group 40-49 years, doubled to 
27.3% in the age group 50-59 years and 25% in the age group 60-69 years and 
age group 70 years and above. For severe ED, the prevalence increased from 
around 30% in the age group 40-49 years and 50-59 years ( 33.3% and 30.0%) to 
around 50% in the age group 60-69 years and above 70 years ( 53.6% and 50.0% 
) (Table 5). 
This difference could be explained by the fact that in young male, the 
cause of ED is more likely to be more psychogenic, in contrast to men older than 
55 or 60 years, a physical cause is more likely (Neil Baun and Jorge Diez, 
1997). Although, ED in men with diabetes is predominantly caused by organic 
factors, psychogenic factors, such as performance anxiety, can contribute to its 
etiology (Rendell, Marc Set a/, 1996). In our study, highest frequency of mild 
ED occurred in relatively younger patients ( 59 years and below ). Therefore, it 
could be these group of patients were having psychogenic or mixed 
(psychogenic and organic) ED, which presented in the form of mild ED (Gideon 
Bosker et a/, NIH, 1994) . If the causes of ED in people with diabetes are 
neuropathy, vascular insufficiency, poor glycemic control, hypertension, low 
testosterone levels, and possibly a history of smoking, in psychogenic ED, the 
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causes are depression, performance anxiety, and relationship problems which are 
more likely to occur in young patients (Neelima V Chu, 2001). 
5.3.2 Duration of diabetes 
The mean duration of diabetes as a whole was 8.3 ± 6.95 years. Seyoum 
B in 1998, found a higher mean duration of diabetes (9.9 ± 6.7 years) among 
292 diabetic Ethiopian male (Seyoum B, 1998). 
In relation to ED, we found a significant difference between the duration 
of diabetes in patients with ED, which was 9.4 ± 7.4 years and without ED, 4.39 
± 2.8 years. Study in Ethiopia found a higher duration of diabetes for ED 
sufferers compared to without ED ( 12.3 years and 8.1 years ). The difference 
was significant, p<O.OO 1 (Seyoum B, 1998). Smilarly, mean duration of diabetes 
was found to be significant in relation to ED in a study done in Senegal, p=0.049 
(Gueye SM et al, 1998). 
We also found that the prevalence of ED increased with age. The 
prevalence of ED was 62.7% for duration group 1-5 years, 76.3% for duration 
group 6-10 years and 100% for the duration above 11 years. For mild ED, the 
highest prevalence was in the duration 31-35 years (66.7%), for moderate ED 
the highest prevalence was in the duration group 21-25 and 31-35 years and for 
severe ED group the highest prevalence was in the duration group 26-30 years 
(1 00%) (Table 6). In study in Italy, Fedele reported a similar increase in 
prevalence of ED with increase in the duration of diabetes, 26.2%, 33.7% and 
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44.7% in the duration group 1-5 years, 6-10 years and 11-30 years respectively 
(Fedele et al, 1998). 
5.3.3 Presence of concomitant disease 
ED is clearly a symptom of many conditions. Diabetes mellitus, 
hypogonadism in association with a number of endocrinologic conditions, 
hypertension, vascular disease, high levels of blood cholesterol, low levels of 
high density lipoprotein, drugs, neurogenic disorders, Peyronie's disease, 
priapism, depression and many chronic diseases, especially renal failure and 
dialysis, have been demonstrated as risk factors for ED (Impotence: NIH 
Consensus Conference, 1993). In this study, we found that presence of 
concomitant diseases had no significant association with ED (p>0.05) (Table 
11). In contrast, Fedele found that medical conditions such as anxiety or 
depression, arthritis, cardiopathy hypercholesterolemia, hypertension, 
stroke/cerebral hemorrhage, gastric ulcer, and pelvic trauma or surgery/radiation 
were associated with an increased risk of ED (Fedele et al, 1998). The odds ratio 
for ED were 1.8 (95% CI 1.4-2.3) for anxiety; 1.5 (95% CI 1.1-1.9) for 
depression; 2.0 (95% Cl 1.4-2.8) for arthritis; 1.7 (95% CI 1.5-2.0) for 
cardiopathy; 1.3 (95% CI 1.1-1.5) for hypercholesterolemia; 1.3 (95% CI 1.2-
1.4) for hypertension; 2.1 (95% CI 1.6-2.9) for stroke/cerebral hemorrhage; 1.2 
(95% Cl 1.0-1.4) for gastric ulcer; 2.3 (95% CI 1.3-4.2) for pelvic trauma; and 
1.4 (95% Cl 1.1-1.8) for pelvic surgery or radiation. 
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Report by Henry A. Fieldman through MMAS study mentioned certain 
treated medical conditions that were associated with ED (Henry A. Fieldman et 
al, 1994). The age-adjusted probability of complete impotence was 39% in 
patients with treated heart disease and 15% in those with treated hypertension. 
Untreated disease which was associated with ED were untreated ulcer (18%), 
untreated arthritis (15%) and untreated allergy (12%). 
5.3.4 History of smoking 
Neelima V Chu et al stated his opinion that smoking is possibly related to 
ED (Neelima V Chu, et al, 2001). Our study found that smoking was 
significantly related to ED, p=0.038 (Table 1 0). There was a similarity in this 
association as reported in previous studies. Henry A Fieldman reported the 
probability of complete impotence was 11% in smokers and 9% in non-smokers 
(p>0.20). Smoking also associated with ED by amplifying the risks of certain 
factors that were associated with ED. In subjects with treated heart disease, the 
age-adjusted probability of complete impotence was 56% for smokers and 21% 
for nonsmoker. Among treated hypertensives, those who smoked had an 
elevated probability of complete impotence (20% ), whereas nonsmoker was 
9.6% (Henry A. Fieldman, 1994). 
Study in Malaysia also showed a significant association between 
smoking and ED (p<0.05) (Thambi /,1997). AI Helali et al studied the pattern of 
erctile dysfunction in J eddah city found that smoker comprised 56% of subject 
with ED which was significant {p<0.05) (Al Helali et al, 2001). 
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A study by Fedele in Italy found that smoking was associated with an 
increased risk of ED. In comparison with never-smokers, the risk was 1.5 (95% 
CI 1.3-1.6) for current smokers and 1.4 (95% CI 1.3-1.6) for ex-smokers (Fedele 
et al, 1998) . 
5.3.5 Treatment of diabetes mellitus 
Among all 126 diabetic patients involved in our study, 94.5% received 
medication for their diabetes. 92.1% took regular tablets medication, while 2.4% 
got insulin treatment (Table 4). According to report by National Institute of 
Health (Impotence: NIH Consensus Conference, 1993), oral hypoglycemic agent 
is one of the drug associated with ED. Our study found that there was no 
significant association between treated diabetes (receiving oral hypoglycemic 
agent or insulin) and ED {p=O. I 77) (Table 12). 
However, Henry A. Fieldman, through his MMAS study, reported that 
diabetic patients that received medication were at increased risk to developed 
ED. He stated the age-adjusted probability of complete impotence was 28% in 
those treated diabetes (Henry A. Fieldman et al, 1994). Dominico Fedele, in his 
study among diabetic patients in Italy also reported a comparison between 
diabetic men treated with diet alone, the odd ratios of ED were 2.1 for men 
managed with oral agents, 3.7 for men those with insulin and 4.1 for those 
managed with oral agents plus insulin. The reason could be due the difference in 
the number of sample. Our small sample (126 patients) might be the cause of 
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this discrepancy. The sample of Fedele's study was 9869 patients while sample 
in MMAS study by Henry . Fieldman was 1290 patients. Therefore it need 
further confirmation by future study. 
5.3.6 Treatment other than diabetes mellitus 
There was a substantial number of our patients received medication other 
than medications for diabetes. The highest being anti-hypertensive medication , 
42.9%. certain antihypertensive, antidepressant, and antipsychotic were 
associated with ED (Impotence: NIH Consensus Conference, 1993). Neelima V. 
Chu et al stated that commonly used drugs that disrupt male sexual function are 
spironolactone, sympathetic blockers such as clonidine, guanethidine, 
methyldopa, thiazide diuretics, most antidepressants, ketoconazole, cimetidine, 
alcohol, methadone, heroin, and cocaine (Neelima V. Chu et al, 2000). Our study 
was using a questionnaire which was adapted from previous large study in 
Malaysia done in 1997 (Thambi L 1998). Therefore, the list of drug or 
medications that we asked the patients the patients was limited to medication 
that was included in the original questionnaire (Table 8). Furthermore, we found 
the drugs were among medication that were commonly prescribed in our country 
in outpatient department. In our study, we found there was no significant 
association between consumption of these medications and ED (p>0.05) (Table 
12). 
Henry et al in his study found dissimilar result. He reported that complete 
impotence was significantly more prevalent in men taking certain medications, 
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anti-hypertensives (14%) and vasodilators (36%). However he found there was 
no correlation between impotence and lipid lowering agents and sympathetic 
drugs. 
5.3. 7 Complications of diabetes 
Table 13 shows that retinopathy was significantly associated with ED. 
Besides retinopathy Fedele found that, arteriopathy, nephropathy, and 
neuropathy was associated with a increased risk of ED (Fedele et a/,1998). 
Meanwhile, Gueye et al in his study among diabetic patients in Senegal found 
only neuropathy significantly correlated with ED ( Gueye et al, 1998). In study in 
Ethiopia, Seyoum B didn't mention a specific complication of diabetes, instead 
patients with complications was significantly associated with ED (Seyoum B et 
al, 1998). 
5.3.8 Knowledge, attitude and practice towards ED 
We found that majority of patients (86%) had a poor knowledge on ED. 
We also found that there was a significant association between knowledge score 
and level of education, p=0.008 (Table 14). 
This result reflects the patients' poor knowledge about ED. The low level 
of knowledge of patients might be due to lack of proper source of information 
regarding ED. Patients could easily find an articles or discussion about ED in 
their daily newspaper or their favourite magazines. 
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The other reason is that ED was not stressed as same as other diseases 
which cause high morbidity and mortality, i.e. ischaemic heart disease or 
chronic disease such as hypertension, diabetes mellitus and dyslipidemia. 
According to NIH Consensus Conference Statement, despite the 
accumulation of a substantial body of scientific information about erectile 
dysfunction, large segments of the public -- as well as the health professions --
remain relatively uninformed, or -- even worse -- misinformed, about much of 
what is known. This lack of information, added to a pervasive reluctance of 
physicians to deal candidly with sexual matters, has resulted in patients being 
denied the benefits of treatment for their sexual concerns. 
In contrast to poor knowledge score, we found that 75% of patients were 
· aware about ED (Figure 5). Since the advent of Sildenafil Citrate, ED issue had 
received more attention by public. The popularity of Viagra, had brought people 
to be more aware of this disease. The way people perceive ED has also changed. 
People could accept that ED is a common condition and it's important cannot be 
taken lightly. 
Most of respondents chose printed materials and friends or neighbors as 
their important source of information regarding ED (Figure 6). As compared to 
health provider, only 15.6% of patients chose health provider as their source of 
information. This might be due to the doctor is not comfortable in addressing the 
issue with their patient. They themselves might not have enough knowledge 
regarding ED. 
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It was not surprised to see the result of high percentage of patients stated 
that their information regarding ED was not enough (Figure 6). Similarly, it 
could be explained by the lack of proper information regarding ED that was 
available for the atients. Furthermore, people regards ED as a sensitive issue, 
especially in Malay culture. Therefore, people are getting informal information 
from friends, neighbors and reading materials which is misleading. 
Pills and hormone were the treatment of choice by majority of patients 
for ED. Pills especially Sildenafil citrate gained high popularity, because of the 
wide coverage in mass media. The effort put by the drug company through 
extensive advertisement all over the world, made pills medication namely 
Sildenafil citrate became an ouitstanding treatment for ED. In the Malaysian 
Consensus guideline for treatment of ED, sildenafil citrate was considered a first 
line treatment for ED, provided there is no contraindication such as ischemic 
heart disease or patient receiving Isosorbide Dinitrate.(Malaysian Consensus 
Statement In Prescribing Sildenafil citrate, 2000). Hormonal treatment was 
chosen by 48% of our respondents. Hormonal treatment was part of traditional 
treatment for ED by traditional healers in Malysia. The role of testosterone is 
still controversial in treating ED, and it is currently being studied. 
Majority of patients are comfortable in discussing about ED with their 
health provider. Only about one fifth of patients feel uncomfortable (Figure 8). 
We didn't ask the patient to specify the reason of not telling the doctor if 
supposed they have ED. In TEDES, it was found that the highest percentage of 
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patient (46%) were in the group of between comfortable and uncomfortable. 
(Kongkanon et al, 2000). 30% of the respondent feel comfortable discussing 
about ED with doctor which is lower than our respondent. Similar result was 
found for number of patient who feel uncomfortable (24%). 
For the health seeking attitude, half of the respondent mentioned that 
they would voluntarily tell their doctor if they suffered from ercetile dysfunction 
(53 %) (Figure 9). In contrast, Kongkanan found in his study that only 8% of 
patients would consult their doctor if they are suffering from ED (Kongkanan et 
a!, 2000). Health seeking attitude was associated with level of education (Table 
16) but not with socioeconomic status (Table 17). According to Asean ED 
Counsil and Training (ED ACT), a few myths exist about ED. Among them is the 
regard of ED as a normal process of aging. The other myth is there is no 
treatment for ED and man should live with ED. 
For the type of health provider that patients chose to consult to supposed 
they had ED, highest percentage ( 41%) chose primary care doctors. Similarly, in 
Thailand the respondent chose their primary care practitioner to consult with, but 
the number was lower (22%). ( Kongkanan eta!, 2000 ) KM Dunn found a 
higher percentage (63%) of patients prefer their primary care practitioner for 
their sexual dysfunction. (KM Dunn et a!, 1998) Primary care doctors are often 
met by patients most of the time whenever patients want to seek treatment. The 
family centered approach in their practice help to bring patients became more 
closer to them. It will enhance the good rapport and break the communication 
barrier between the doctor and patients, therefore patients will felt at ease to 
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discuss any sensitive issue such as ED with them. This positive aspect in health 
seeking attitude was by far one of the most important factor not only in term 
screening for ED but also to increase the knowledge of patients regarding ED. 
6.0 CONCLUSION 
ED is a common condition. There was a high prevalence of ED 
undiagnosed among diabetic patients in Kota Bharu, Kelantan. In fact it was 
highest as compared to previous study of ED among diabetic patients done in 
overseas. 
Among all characteristics of diabetic patients, age, duration of diabetes, 
retinopathy and history of smoking significantly associated with ED. The 
mean age for ED was 56.3(8.8) years whereas the mean duration of diabetes for 
developing ED was 9.44(6.5) years .. 
There was a high percentage of diabetic patient has poor knowledge 
about ED. Factors that were significantly associated knowledge regarding ED 
was level of education and socioeconomic status. Patient who has higher level of 
education and higher socioeconomic status has better knowledge. 
Health providers was not a main source of information regarding ED. 
Patients were getting information mostly from improper source such as printed 
materials and their friends and neighbors. Information regarding ED was also 
regarded as inadequate. 
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Only half of patients will seek treatment for erectile problem. Most of 
them prefer primary care doctors to consult. Health seeking attitude in patients 
was associated with their level of education. Patients who has high and moderate 
level of education tend to have positive health seeking attitude. 
7.0 RECOMMENDATION 
7.1 Screening of ED to be done routinely among all diabetic patients. This 
could be done by a simple 5 items International Index of ED 
questionannire. This questionnaire should be readily available in every 
diabetic clinics. 
7.2 Doctors who involve in management of patients should increase their 
knowledge and learn to be comfortable in discussing about ED with their 
patients. This issue could not be addressed properly unless the doctors 
feel comfortable themselves. There is no other way to gain comfortable 
unless they practice it. 
7.3 Patients should also encouraged to seek treatment. There are many 
barriers, however. These include traditional social stigmas attached to 
ED, a man's own embarrassment, misunderstandings about the 
effectiveness of the treatments available, and myths and superstitious that 
have many men avoiding their doctors in favor of other methods of 
treatment e.g. traditional medicines. Increasing openness about general 
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sexual health issues, means many men are becoming more 
knowledgeable about this often devastating condition. 
7.4 For future research, we suggest a follow up study among this sample of 
patients to find an effective way of increasing patients knowledge, imply 
a positive attitude and practice towards ED. A intervention study 
involving health education can be conducted and the knowledge score 
and health seeking attitude assessed before and after the intervention. 
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